GB1440478A - 4-thiopyrimido-4,5-d-pyrimidines - Google Patents
4-thiopyrimido-4,5-d-pyrimidinesInfo
- Publication number
- GB1440478A GB1440478A GB4572473A GB4572473A GB1440478A GB 1440478 A GB1440478 A GB 1440478A GB 4572473 A GB4572473 A GB 4572473A GB 4572473 A GB4572473 A GB 4572473A GB 1440478 A GB1440478 A GB 1440478A
- Authority
- GB
- United Kingdom
- Prior art keywords
- unsubstituted
- pyrimidines
- aralkyl
- oct
- unsaturated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- JOZPEVMCAKXSEY-UHFFFAOYSA-N pyrimido[5,4-d]pyrimidine Chemical class N1=CN=CC2=NC=NC=C21 JOZPEVMCAKXSEY-UHFFFAOYSA-N 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19722248232 DE2248232A1 (de) | 1972-10-02 | 1972-10-02 | 4-thiopyrimido eckige klammer auf 4,5-d eckige klammer zu pyrimidine |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1440478A true GB1440478A (en) | 1976-06-23 |
Family
ID=5857974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4572473A Expired GB1440478A (en) | 1972-10-02 | 1973-10-01 | 4-thiopyrimido-4,5-d-pyrimidines |
Country Status (4)
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8680108B2 (en) | 2009-12-18 | 2014-03-25 | Incyte Corporation | Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors |
US8759359B2 (en) | 2009-12-18 | 2014-06-24 | Incyte Corporation | Substituted heteroaryl fused derivatives as PI3K inhibitors |
US8940752B2 (en) | 2009-06-29 | 2015-01-27 | Incyte Corporation | Pyrimidinones as PI3K inhibitors |
US9062055B2 (en) | 2010-06-21 | 2015-06-23 | Incyte Corporation | Fused pyrrole derivatives as PI3K inhibitors |
US9096600B2 (en) | 2010-12-20 | 2015-08-04 | Incyte Corporation | N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors |
US9108984B2 (en) | 2011-03-14 | 2015-08-18 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors |
US9126948B2 (en) | 2011-03-25 | 2015-09-08 | Incyte Holdings Corporation | Pyrimidine-4,6-diamine derivatives as PI3K inhibitors |
US9193721B2 (en) | 2010-04-14 | 2015-11-24 | Incyte Holdings Corporation | Fused derivatives as PI3Kδ inhibitors |
US9199982B2 (en) | 2011-09-02 | 2015-12-01 | Incyte Holdings Corporation | Heterocyclylamines as PI3K inhibitors |
US9309251B2 (en) | 2012-04-02 | 2016-04-12 | Incyte Holdings Corporation | Bicyclic azaheterocyclobenzylamines as PI3K inhibitors |
US9732097B2 (en) | 2015-05-11 | 2017-08-15 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
US9988401B2 (en) | 2015-05-11 | 2018-06-05 | Incyte Corporation | Crystalline forms of a PI3K inhibitor |
US10077277B2 (en) | 2014-06-11 | 2018-09-18 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors |
US10336759B2 (en) | 2015-02-27 | 2019-07-02 | Incyte Corporation | Salts and processes of preparing a PI3K inhibitor |
US12226418B2 (en) | 2018-06-01 | 2025-02-18 | Incyte Corporation | Dosing regimen for the treatment of PI3K related disorders |
-
1972
- 1972-10-02 DE DE19722248232 patent/DE2248232A1/de not_active Withdrawn
-
1973
- 1973-10-01 CH CH1403973A patent/CH582704A5/xx not_active IP Right Cessation
- 1973-10-01 GB GB4572473A patent/GB1440478A/en not_active Expired
- 1973-10-01 FR FR7335019A patent/FR2201098B1/fr not_active Expired
Cited By (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9434746B2 (en) | 2009-06-29 | 2016-09-06 | Incyte Corporation | Pyrimidinones as PI3K inhibitors |
US8940752B2 (en) | 2009-06-29 | 2015-01-27 | Incyte Corporation | Pyrimidinones as PI3K inhibitors |
US10428087B2 (en) | 2009-06-29 | 2019-10-01 | Incyte Corporation | Pyrimidinones as PI3K inhibitors |
US10829502B2 (en) | 2009-06-29 | 2020-11-10 | Incyte Corporation | Pyrimidinones as PI3K inhibitors |
US11401280B2 (en) | 2009-06-29 | 2022-08-02 | Incyte Holdings Corporation | Pyrimidinones as PI3K inhibitors |
US9975907B2 (en) | 2009-06-29 | 2018-05-22 | Incyte Holdings Corporation | Pyrimidinones as PI3K inhibitors |
US8759359B2 (en) | 2009-12-18 | 2014-06-24 | Incyte Corporation | Substituted heteroaryl fused derivatives as PI3K inhibitors |
US8680108B2 (en) | 2009-12-18 | 2014-03-25 | Incyte Corporation | Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors |
US9403847B2 (en) | 2009-12-18 | 2016-08-02 | Incyte Holdings Corporation | Substituted heteroaryl fused derivatives as P13K inhibitors |
US9193721B2 (en) | 2010-04-14 | 2015-11-24 | Incyte Holdings Corporation | Fused derivatives as PI3Kδ inhibitors |
US9062055B2 (en) | 2010-06-21 | 2015-06-23 | Incyte Corporation | Fused pyrrole derivatives as PI3K inhibitors |
US9527848B2 (en) | 2010-12-20 | 2016-12-27 | Incyte Holdings Corporation | N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors |
US9815839B2 (en) | 2010-12-20 | 2017-11-14 | Incyte Corporation | N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors |
US9096600B2 (en) | 2010-12-20 | 2015-08-04 | Incyte Corporation | N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors |
US9108984B2 (en) | 2011-03-14 | 2015-08-18 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors |
US9126948B2 (en) | 2011-03-25 | 2015-09-08 | Incyte Holdings Corporation | Pyrimidine-4,6-diamine derivatives as PI3K inhibitors |
US9199982B2 (en) | 2011-09-02 | 2015-12-01 | Incyte Holdings Corporation | Heterocyclylamines as PI3K inhibitors |
US11819505B2 (en) | 2011-09-02 | 2023-11-21 | Incyte Corporation | Heterocyclylamines as PI3K inhibitors |
US10376513B2 (en) | 2011-09-02 | 2019-08-13 | Incyte Holdings Corporation | Heterocyclylamines as PI3K inhibitors |
US11433071B2 (en) | 2011-09-02 | 2022-09-06 | Incyte Corporation | Heterocyclylamines as PI3K inhibitors |
US12201636B2 (en) | 2011-09-02 | 2025-01-21 | Incyte Corporation | Heterocyclylamines as PI3K inhibitors |
US10092570B2 (en) | 2011-09-02 | 2018-10-09 | Incyte Holdings Corporation | Heterocyclylamines as PI3K inhibitors |
US9730939B2 (en) | 2011-09-02 | 2017-08-15 | Incyte Holdings Corporation | Heterocyclylamines as PI3K inhibitors |
US10646492B2 (en) | 2011-09-02 | 2020-05-12 | Incyte Corporation | Heterocyclylamines as PI3K inhibitors |
US9707233B2 (en) | 2011-09-02 | 2017-07-18 | Incyte Holdings Corporation | Heterocyclylamines as PI3K inhibitors |
US9309251B2 (en) | 2012-04-02 | 2016-04-12 | Incyte Holdings Corporation | Bicyclic azaheterocyclobenzylamines as PI3K inhibitors |
US10259818B2 (en) | 2012-04-02 | 2019-04-16 | Incyte Corporation | Bicyclic azaheterocyclobenzylamines as PI3K inhibitors |
US9944646B2 (en) | 2012-04-02 | 2018-04-17 | Incyte Holdings Corporation | Bicyclic azaheterocyclobenzylamines as PI3K inhibitors |
US11999751B2 (en) | 2014-06-11 | 2024-06-04 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors |
US11130767B2 (en) | 2014-06-11 | 2021-09-28 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors |
US10077277B2 (en) | 2014-06-11 | 2018-09-18 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors |
US10479803B2 (en) | 2014-06-11 | 2019-11-19 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors |
US11084822B2 (en) | 2015-02-27 | 2021-08-10 | Incyte Corporation | Salts and processes of preparing a PI3K inhibitor |
US10336759B2 (en) | 2015-02-27 | 2019-07-02 | Incyte Corporation | Salts and processes of preparing a PI3K inhibitor |
US12024522B2 (en) | 2015-02-27 | 2024-07-02 | Incyte Corporation | Salts and processes of preparing a PI3K inhibitor |
US10125150B2 (en) | 2015-05-11 | 2018-11-13 | Incyte Corporation | Crystalline forms of a PI3K inhibitor |
US9988401B2 (en) | 2015-05-11 | 2018-06-05 | Incyte Corporation | Crystalline forms of a PI3K inhibitor |
US9732097B2 (en) | 2015-05-11 | 2017-08-15 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
US12226418B2 (en) | 2018-06-01 | 2025-02-18 | Incyte Corporation | Dosing regimen for the treatment of PI3K related disorders |
Also Published As
Publication number | Publication date |
---|---|
FR2201098B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1976-09-03 |
DE2248232A1 (de) | 1974-04-11 |
CH582704A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1976-12-15 |
FR2201098A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1974-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1440478A (en) | 4-thiopyrimido-4,5-d-pyrimidines | |
GB1351263A (en) | Eburnane derivatives | |
ES278057A1 (es) | Procedimiento para la preparación de lincomicina | |
GB1481048A (en) | 7-hydroxy-delta8-tetrahydrocannabinols | |
GB1266091A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
GB1525449A (en) | Cosmetic preparation containing agents for keeping the skin moist | |
ES389180A1 (es) | Procedimiento para la preparacion de derivados de la dihi- dro-3,4 isoquinoleina. | |
GB1187825A (en) | Ribofuranosyl Derivatives | |
GB1499480A (en) | Process for the manufacture of pure substituted 2,5-diarylaminoterephthalates and the corresponding free acids | |
ES415226A1 (es) | Procedimiento para la obtencion de ascorbato de vincamina. | |
ES313072A1 (es) | Procedimiento para la produccion del antibiotico rhi 12-648. | |
ES422433A1 (es) | Un procedimiento para la produccion del antibiotico a-287. | |
ES452736A1 (es) | Un procedimiento para preparar compuestos de aroil-fenildi- deno y aroil-fenilnaftaleno. | |
ES426711A1 (es) | Procedimiento para la preparacion de 17b-hidroxi-16,16-di- metilester-4en-3-ona. | |
GB1378408A (en) | Method of preparation 1-beta-d or l-arabinofuranosylcytosine | |
GB1331161A (en) | Amino-s-triazolylbenzenesulphonamides | |
GB1236947A (en) | Process for the preparation of piperazine derivatives | |
ES416618A1 (es) | Procedimiento para la preparacion de derivados de dihidro- digoxina. | |
GB1129209A (en) | Tricyclic n-alkylated derivatives of acetamide | |
GB1387511A (en) | Method for the preparation of hydrogen peroxide | |
ES309611A1 (es) | Procedimiento para la preparacion de lincomicina b. | |
GB1274831A (en) | New oleanene derivatives | |
GB1445242A (en) | Control system of an electrode boiler | |
ES415515A1 (es) | Procedimiento para la preparacion de nuevas delta 4 ndelta5dehidrocardenolidas. | |
ES285719A1 (es) | Procedimiento para la produccion de los acidos lisérgico o isolisérgico y sus derivados |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |